SCOTUS Won't Review Rulings for Liquidia That Invalidate United Therapeutics’ Patent

 

• U.S. Supreme Court denied United Therapeutics’ petition to appeal rulings that found all claims of U.S. Patent No. 10,716,793 (‘793 Patent) were invalid
• Decisions that Liquidia does not infringe anyidia  valid claims of the three patents originally asserted by United Therapeutics are now final and not subject to further appeal

https://www.globenewswire.com/news-release/2024/10/07/2959046/0/en/United-States-Supreme-Court-Declines-to-Review-Rulings-that-Invalidate-United-Therapeutics-Patent.html